The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Localized low‐level re‐expression of high‐affinity mesolimbic nicotinic acetylcholine receptors restores nicotine‐induced locomotion but not place conditioning
Open accessAbstract
High‐affinity, β2‐subunit‐containing (β2*) nicotinic acetylcholine receptors (nAChRs) are essential for nicotine reinforcement; however, these nAChRs are found on both gamma‐aminobutyric acid (GABA) and dopaminergic (DA) neurons in the ventral tegmental area (VTA) and also on terminals of glutamatergic and cholinergic neurons projecting from the pedunculopontine tegmental area and the laterodorsal tegmental nucleus. Thus, systemic nicotine administration stimulates many different neuronal subtypes in various brain nuclei. To identify neurons in which nAChRs must be expressed to mediate effects of systemic nicotine, we investigated responses in mice with low‐level, localized expression of β2* nAChRs in the midbrain/VTA. Nicotine‐induced GABA and DA release were partially rescued in striatal synaptosomes from transgenic mice compared with tissue from β2 knockout mice. Nicotine‐induced locomotor activation, but not place preference, was rescued in mice with low‐level VTA expression, suggesting that low‐level expression of β2* nAChRs in DA neurons is not sufficient to support nicotine reward. In contrast to control mice, transgenic mice with low‐level β2* nAChR expression in the VTA showed no increase in overall levels of cyclic AMP response element‐binding protein (CREB) but did show an increase in CREB phosphorylation in response to exposure to a nicotine‐paired chamber. Thus, CREB activation in the absence of regulation of total CREB levels during place preference testing was not sufficient to support nicotine place preference in β2 trangenic mice. This suggests that partial activation of high‐affinity nAChRs in VTA might block the rewarding effects of nicotine, providing a potential mechanism for the ability of nicotinic partial agonists to aid in smoking cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
Self-citationNicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566
Walters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206
Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156
Flagged first, then by citations
Research works printed but not linked: 36
- 10.1523/JNEUROSCI.16-02-00714.1996 · DOI
- 10.1046/j.1471-4159.2003.01640.x · DOI · Paper page
- 10.1523/JNEUROSCI.2284-07.2007 · DOI · Paper page
- 10.1124/mol.54.3.495 · DOI
- 10.1016/0006-2952(90)90436-O · DOI
- 10.1016/0006-8993(94)90401-4 · DOI · Paper page
- 10.1038/nn1661 · DOI
- 10.1016/j.neuroscience.2008.02.003 · DOI
- 10.1124/mol.105.015925 · DOI
- 10.1016/j.brainresrev.2007.05.004 · DOI · Paper page
- 10.1523/JNEUROSCI.4542-05.2006 · DOI · Paper page
- 10.1111/j.1460-9568.2005.04353.x · DOI
- 10.1038/45790 · DOI · Paper page
- King S.L., 2003, Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior, J Neurosci, 23, 3837, 10.1523/JNEUROSCI.23-09-03837.2003 · DOI · Paper page
- 10.1016/j.neuropharm.2004.06.024 · DOI · Paper page
- 10.1046/j.1460-9568.2001.01458.x · DOI
- 10.1038/sj.mp.4001197 · DOI
- 10.1523/JNEUROSCI.22-19-08653.2002 · DOI
- 10.1016/S0896-6273(00)00042-8 · DOI · Paper page
- 10.1016/S0896-6273(02)00625-6 · DOI · Paper page
- Marks M.J., 1999, Two pharmacologically distinct components of nicotinic receptor‐mediated rubidium efflux in mouse brain require the beta2 subunit, J Pharmaco Exp Ther, 289, 1090, 10.1016/S0022-3565(24)38240-0 · DOI · Paper page
- 10.1046/j.1460-9568.2003.02564.x · DOI · Paper page
- 10.1016/0024-3205(94)00656-3 · DOI · Paper page
- 10.1016/0091-3057(94)90563-0 · DOI
- 10.1038/34413 · DOI · Paper page
- 10.1124/mol.65.6.1526 · DOI
- 10.1124/mol.106.031492 · DOI
- 10.1126/science.1099420 · DOI · Paper page
- 10.1046/j.1471-4159.2003.02090.x · DOI
- 10.1016/j.neuron.2005.05.005 · DOI
- Whiteaker P., 2000, 125I‐Alpha‐conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain, Mol Pharmacol, 57, 913, 10.1016/S0026-895X(24)26500-7 · DOI
- 10.1002/cne.21181 · DOI
- 10.1523/JNEUROSCI.08-09-03395.1988 · DOI
- 10.1093/hmg/ddm027 · DOI
- 10.1523/JNEUROSCI.18-12-04461.1998 · DOI
- 10.1124/mol.54.6.1124 · DOI · Paper page
Cited by
Sorted by citations
Nicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439
Self-citationMcGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165
Self-citationMechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Self-citationLearning from Action: Reconsidering Movement Signaling in Midbrain Dopamine Neuron Activity
Coddington, L. T., & Dudman, J. T. (2019) · Neuron · doi:10.1016/j.neuron.2019.08.036 · Cited by 150
Brunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95
“Recovery of α 6 receptor subunit mRNA in the VTA ought to rescue expression of α 6 β 2*nAChRs on neuron terminals in multiple VTA projection regions, including the NAc core and shell, the dorsal striatum, and the anterior cingulate (Mineur et al , 2009).”
Self-citationMelis, M., Carta, S., Fattore, L., Tolu, S., Yasar, S., Goldberg, S. R., Fratta, W., Maskos, U., & Pistis, M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.016 · Cited by 89
Metadata
- Authors
- Mineur, Y. S., Brunzell, D. H., Grady, S. R., Lindstrom, J. M., McIntosh, J. M., Marks, M. J., King, S. L., & Picciotto, M. R.
- Affiliations
- Yale University (US)
- Virginia Commonwealth University (US)
- University of Colorado Boulder (US)
- University of Pennsylvania (US)
- University of Utah (US)
- University of Sussex (GB)
- Corresponding author
- Picciotto, M. R.
- Venue
- Genes, Brain and Behavior
- Publisher
- Wiley
- Published
- 2009-04
- Volume
- 8
- Issue
- 3
- Pages
- 257-266
- ISSN
- 1601-183X (ISSN-L)
- 1601-1848
- PMC
- PMC2672109
- OpenAlex
- W1967344144
- Cited by
- 33
- References
- 5
- Citations by year
- 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 6 · 2014: 5 · 2013: 2 · 2012: 4
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes Brain & Behavior (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (P50AA015632, AA15632)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (DA14241, K02DA000436, DA 10455, DA012242, R01DA014241, R01DA003194, DA003194, R01DA012242, R29DA010455, R01DA010455, DA 00436, R37DA014241)
- National Institute of General Medical Sciences (P01GM048677, GM48677)
- National Institute of Neurological Disorders and Stroke (NS11323, R01NS011323)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, beta2 nAChR, ventral tegmental area, nicotine reward, place preference, dopaminergic neurons, GABAergic neurons, CREB phosphorylation, smoking cessation, transgenic mice
- MeSH terms
- Animals, Conditioning, Psychological, Dopamine, gamma-Aminobutyric Acid, Gene Expression Regulation, Locomotion, Mice, Inbred C57BL, Mice, Transgenic, Nicotine, Phosphorylation, Receptors, Nicotinic, Reward, Synaptosomes, Tobacco Use Disorder, Cyclic AMP Response Element-Binding Protein, Ventral Tegmental Area, Presynaptic Terminals, Nicotinic Agonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review